Submitted:
24 April 2021
Posted:
27 April 2021
Withdrawn:
15 June 2021
This preprint has been withdrawn
Preprint
Article
This version is not peer-reviewed.
Withdrawn:
Dabrafenib, a selective BRAFV600E inhibitor, is not able to reverse the CpG island methylator phenotype in RKO colorectal cell line
MDPI Initiatives
Important Links
© 2026 MDPI (Basel, Switzerland) unless otherwise stated